Individuals with metabolic syndrome features that span multiple domains (visceral obesity, insulin resistance, dyslipidemia) who want comprehensive metabolic intervention
Humans get it from dietary sources that include animal-based foods such as meat, fish, milk, cheese, and eggs
This type of medication behaves similarly to natural GLP-1 hormones in the body by promoting the production of insulin by the pancreas, supporting a sense of satiety while also slowing the movement of food along the digestive tract and by inhibiting the secretion of glucagon as food is digested
GLP-1-based therapies are legitimate prescription medications for approved medical conditions, and their use is protected health information under HIPAA regulations in the United States
Compounded GLP-1 medications use the same active pharmaceutical ingredients as brand names, prepared under pharmaceutical-grade standards
But outreach is still needed to fully inform both patients as well as providers about the program, says Anders Gilberg, senior vice president of government affairs for the Medical Group Management Association
